Covid-19 Impact on Global RNA Based Therapeutics Market Size, Status and Forecast 2020-2026

July 2020 | 91 pages | ID: C50832250E9EEN
QYResearch

Abstracts

This report focuses on the global RNA Based Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the RNA Based Therapeutics development in North America, Europe, China and Japan.

The key players covered in this study

• ISIS pharmaceuticals (USA)
• Quark Pharmaceuticals (USA)
• Alnylam Pharmaceuticals (USA)
• Dicerna Pharmaceuticals (USA)
• Tekmira Pharmaceuticals Corp. (Canada)
• Benitec Biopharma Limited (Australia)
• Genzyme Corporation (USA)
• Silence Therapeutics PLC (UK)
• Cenix BioScience GmbH (Germany)

Market segment by Type, the product can be split into

• qRT-PCR
• RNA Interference (RNAi) Technologies
• RNA Antisense
• Inhibition
• Microarrays
• Labeling
• Purification

Market segment by Application, split into

• Cardiovascular
• Kidney Diseases
• Oncology
• Infectious Diseases
• Metabolic Disorders

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan

The study objectives of this report are:

• To analyze global RNA Based Therapeutics status, future forecast, growth opportunity, key market and key players.
• To present the RNA Based Therapeutics development in North America, Europe, China and Japan.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of RNA Based Therapeutics are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by RNA Based Therapeutics Revenue
1.4 Covid-19 Implications on Market by Type
  1.4.1 Global RNA Based Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 qRT-PCR
  1.4.3 RNA Interference (RNAi) Technologies
  1.4.4 RNA Antisense
  1.4.5 Inhibition
  1.4.6 Microarrays
  1.4.7 Labeling
  1.4.8 Purification
1.5 Covid-19 Implications on Market by Application
  1.5.1 Global RNA Based Therapeutics Market Share by Application: 2020 VS 2026
  1.5.2 Cardiovascular
  1.5.3 Kidney Diseases
  1.5.4 Oncology
  1.5.5 Infectious Diseases
  1.5.6 Metabolic Disorders
1.6 Coronavirus Disease 2019 (Covid-19): RNA Based Therapeutics Industry Impact
  1.6.1 How the Covid-19 is Affecting the RNA Based Therapeutics Industry
    1.6.1.1 RNA Based Therapeutics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and RNA Based Therapeutics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for RNA Based Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Covid-19 Implications on Global RNA Based Therapeutics Market Perspective (2015-2026)
2.2 Covid-19 Implications on Global RNA Based Therapeutics Growth Trends by Regions
  2.2.1 RNA Based Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 RNA Based Therapeutics Historic Market Share by Regions (2015-2020)
  2.2.3 RNA Based Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 RNA Based Therapeutics Market Growth Strategy
  2.3.6 Primary Interviews with Key RNA Based Therapeutics Players (Opinion Leaders)

3 COVID-19 IMPLICATIONS ON COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top RNA Based Therapeutics Players by Market Size
  3.1.1 Global Top RNA Based Therapeutics Players by Revenue (2015-2020)
  3.1.2 Global RNA Based Therapeutics Revenue Market Share by Players (2015-2020)
  3.1.3 Global RNA Based Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global RNA Based Therapeutics Market Concentration Ratio
  3.2.1 Global RNA Based Therapeutics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by RNA Based Therapeutics Revenue in 2019
3.3 RNA Based Therapeutics Key Players Head office and Area Served
3.4 Key Players RNA Based Therapeutics Product Solution and Service
3.5 Date of Enter into RNA Based Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 COVID-19 IMPLICATIONS ON MARKET SIZE BY TYPE (2015-2026)

4.1 Global RNA Based Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global RNA Based Therapeutics Forecasted Market Size by Type (2021-2026)

5 COVID-19 IMPLICATIONS ON MARKET SIZE BY APPLICATION (2015-2026)

5.1 Global RNA Based Therapeutics Market Size by Application (2015-2020)
5.2 Global RNA Based Therapeutics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America RNA Based Therapeutics Market Size (2015-2020)
6.2 RNA Based Therapeutics Key Players in North America (2019-2020)
6.3 North America RNA Based Therapeutics Market Size by Type (2015-2020)
6.4 North America RNA Based Therapeutics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe RNA Based Therapeutics Market Size (2015-2020)
7.2 RNA Based Therapeutics Key Players in Europe (2019-2020)
7.3 Europe RNA Based Therapeutics Market Size by Type (2015-2020)
7.4 Europe RNA Based Therapeutics Market Size by Application (2015-2020)

8 CHINA

8.1 China RNA Based Therapeutics Market Size (2015-2020)
8.2 RNA Based Therapeutics Key Players in China (2019-2020)
8.3 China RNA Based Therapeutics Market Size by Type (2015-2020)
8.4 China RNA Based Therapeutics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan RNA Based Therapeutics Market Size (2015-2020)
9.2 RNA Based Therapeutics Key Players in Japan (2019-2020)
9.3 Japan RNA Based Therapeutics Market Size by Type (2015-2020)
9.4 Japan RNA Based Therapeutics Market Size by Application (2015-2020)

10KEY PLAYERS PROFILES

10.1 ISIS pharmaceuticals (USA)
  10.1.1 ISIS pharmaceuticals (USA) Company Details
  10.1.2 ISIS pharmaceuticals (USA) Business Overview and Its Total Revenue
  10.1.3 ISIS pharmaceuticals (USA) RNA Based Therapeutics Introduction
  10.1.4 ISIS pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020))
  10.1.5 ISIS pharmaceuticals (USA) Recent Development
10.2 Quark Pharmaceuticals (USA)
  10.2.1 Quark Pharmaceuticals (USA) Company Details
  10.2.2 Quark Pharmaceuticals (USA) Business Overview and Its Total Revenue
  10.2.3 Quark Pharmaceuticals (USA) RNA Based Therapeutics Introduction
  10.2.4 Quark Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.2.5 Quark Pharmaceuticals (USA) Recent Development
10.3 Alnylam Pharmaceuticals (USA)
  10.3.1 Alnylam Pharmaceuticals (USA) Company Details
  10.3.2 Alnylam Pharmaceuticals (USA) Business Overview and Its Total Revenue
  10.3.3 Alnylam Pharmaceuticals (USA) RNA Based Therapeutics Introduction
  10.3.4 Alnylam Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.3.5 Alnylam Pharmaceuticals (USA) Recent Development
10.4 Dicerna Pharmaceuticals (USA)
  10.4.1 Dicerna Pharmaceuticals (USA) Company Details
  10.4.2 Dicerna Pharmaceuticals (USA) Business Overview and Its Total Revenue
  10.4.3 Dicerna Pharmaceuticals (USA) RNA Based Therapeutics Introduction
  10.4.4 Dicerna Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.4.5 Dicerna Pharmaceuticals (USA) Recent Development
10.5 Tekmira Pharmaceuticals Corp. (Canada)
  10.5.1 Tekmira Pharmaceuticals Corp. (Canada) Company Details
  10.5.2 Tekmira Pharmaceuticals Corp. (Canada) Business Overview and Its Total Revenue
  10.5.3 Tekmira Pharmaceuticals Corp. (Canada) RNA Based Therapeutics Introduction
  10.5.4 Tekmira Pharmaceuticals Corp. (Canada) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.5.5 Tekmira Pharmaceuticals Corp. (Canada) Recent Development
10.6 Benitec Biopharma Limited (Australia)
  10.6.1 Benitec Biopharma Limited (Australia) Company Details
  10.6.2 Benitec Biopharma Limited (Australia) Business Overview and Its Total Revenue
  10.6.3 Benitec Biopharma Limited (Australia) RNA Based Therapeutics Introduction
  10.6.4 Benitec Biopharma Limited (Australia) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.6.5 Benitec Biopharma Limited (Australia) Recent Development
10.7 Genzyme Corporation (USA)
  10.7.1 Genzyme Corporation (USA) Company Details
  10.7.2 Genzyme Corporation (USA) Business Overview and Its Total Revenue
  10.7.3 Genzyme Corporation (USA) RNA Based Therapeutics Introduction
  10.7.4 Genzyme Corporation (USA) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.7.5 Genzyme Corporation (USA) Recent Development
10.8 Silence Therapeutics PLC (UK)
  10.8.1 Silence Therapeutics PLC (UK) Company Details
  10.8.2 Silence Therapeutics PLC (UK) Business Overview and Its Total Revenue
  10.8.3 Silence Therapeutics PLC (UK) RNA Based Therapeutics Introduction
  10.8.4 Silence Therapeutics PLC (UK) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.8.5 Silence Therapeutics PLC (UK) Recent Development
10.9 Cenix BioScience GmbH (Germany)
  10.9.1 Cenix BioScience GmbH (Germany) Company Details
  10.9.2 Cenix BioScience GmbH (Germany) Business Overview and Its Total Revenue
  10.9.3 Cenix BioScience GmbH (Germany) RNA Based Therapeutics Introduction
  10.9.4 Cenix BioScience GmbH (Germany) Revenue in RNA Based Therapeutics Business (2015-2020)
  10.9.5 Cenix BioScience GmbH (Germany) Recent Development

11ANALYST'S VIEWPOINTS/CONCLUSIONS

12APPENDIX

12.1 Research Methodology
  12.1.1 Methodology/Research Approach
  12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. RNA Based Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by RNA Based Therapeutics Revenue
Table 3. Ranking of Global Top RNA Based Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global RNA Based Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of qRT-PCR
Table 6. Key Players of RNA Interference (RNAi) Technologies
Table 7. Key Players of RNA Antisense
Table 8. Key Players of Inhibition
Table 9. Key Players of Microarrays
Table 10. Key Players of Labeling
Table 11. Key Players of Purification
Table 12. COVID-19 Impact Global Market: (Four RNA Based Therapeutics Market Size Forecast Scenarios)
Table 13. Opportunities and Trends for RNA Based Therapeutics Players in the COVID-19 Landscape
Table 14. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 15. Key Regions/Countries Measures against Covid-19 Impact
Table 16. Proposal for RNA Based Therapeutics Players to Combat Covid-19 Impact
Table 17. Global RNA Based Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 18. Global RNA Based Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 19. Global RNA Based Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 20. Global RNA Based Therapeutics Market Share by Regions (2015-2020)
Table 21. Global RNA Based Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 22. Global RNA Based Therapeutics Market Share by Regions (2021-2026)
Table 23. Market Top Trends
Table 24. Key Drivers: Impact Analysis
Table 25. Key Challenges
Table 26. RNA Based Therapeutics Market Growth Strategy
Table 27. Main Points Interviewed from Key RNA Based Therapeutics Players
Table 28. Global RNA Based Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 29. Global RNA Based Therapeutics Market Share by Players (2015-2020)
Table 30. Global Top RNA Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Based Therapeutics as of 2019)
Table 31. Global RNA Based Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 32. Key Players Headquarters and Area Served
Table 33. Key Players RNA Based Therapeutics Product Solution and Service
Table 34. Date of Enter into RNA Based Therapeutics Market
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global RNA Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. Global RNA Based Therapeutics Market Size Share by Type (2015-2020)
Table 38. Global RNA Based Therapeutics Revenue Market Share by Type (2021-2026)
Table 39. Global RNA Based Therapeutics Market Size Share by Application (2015-2020)
Table 40. Global RNA Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. Global RNA Based Therapeutics Market Size Share by Application (2021-2026)
Table 42. North America Key Players RNA Based Therapeutics Revenue (2019-2020) (Million US$)
Table 43. North America Key Players RNA Based Therapeutics Market Share (2019-2020)
Table 44. North America RNA Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. North America RNA Based Therapeutics Market Share by Type (2015-2020)
Table 46. North America RNA Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. North America RNA Based Therapeutics Market Share by Application (2015-2020)
Table 48. Europe Key Players RNA Based Therapeutics Revenue (2019-2020) (Million US$)
Table 49. Europe Key Players RNA Based Therapeutics Market Share (2019-2020)
Table 50. Europe RNA Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. Europe RNA Based Therapeutics Market Share by Type (2015-2020)
Table 52. Europe RNA Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. Europe RNA Based Therapeutics Market Share by Application (2015-2020)
Table 54. China Key Players RNA Based Therapeutics Revenue (2019-2020) (Million US$)
Table 55. China Key Players RNA Based Therapeutics Market Share (2019-2020)
Table 56. China RNA Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. China RNA Based Therapeutics Market Share by Type (2015-2020)
Table 58. China RNA Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. China RNA Based Therapeutics Market Share by Application (2015-2020)
Table 60. Japan Key Players RNA Based Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Japan Key Players RNA Based Therapeutics Market Share (2019-2020)
Table 62. Japan RNA Based Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Japan RNA Based Therapeutics Market Share by Type (2015-2020)
Table 64. Japan RNA Based Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Japan RNA Based Therapeutics Market Share by Application (2015-2020)
Table 66. ISIS pharmaceuticals (USA) Company Details
Table 67. ISIS pharmaceuticals (USA) Business Overview
Table 68. ISIS pharmaceuticals (USA) Product
Table 69. ISIS pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 70. ISIS pharmaceuticals (USA) Recent Development
Table 71. Quark Pharmaceuticals (USA) Company Details
Table 72. Quark Pharmaceuticals (USA) Business Overview
Table 73. Quark Pharmaceuticals (USA) Product
Table 74. Quark Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 75. Quark Pharmaceuticals (USA) Recent Development
Table 76. Alnylam Pharmaceuticals (USA) Company Details
Table 77. Alnylam Pharmaceuticals (USA) Business Overview
Table 78. Alnylam Pharmaceuticals (USA) Product
Table 79. Alnylam Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 80. Alnylam Pharmaceuticals (USA) Recent Development
Table 81. Dicerna Pharmaceuticals (USA) Company Details
Table 82. Dicerna Pharmaceuticals (USA) Business Overview
Table 83. Dicerna Pharmaceuticals (USA) Product
Table 84. Dicerna Pharmaceuticals (USA) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 85. Dicerna Pharmaceuticals (USA) Recent Development
Table 86. Tekmira Pharmaceuticals Corp. (Canada) Company Details
Table 87. Tekmira Pharmaceuticals Corp. (Canada) Business Overview
Table 88. Tekmira Pharmaceuticals Corp. (Canada) Product
Table 89. Tekmira Pharmaceuticals Corp. (Canada) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 90. Tekmira Pharmaceuticals Corp. (Canada) Recent Development
Table 91. Benitec Biopharma Limited (Australia) Company Details
Table 92. Benitec Biopharma Limited (Australia) Business Overview
Table 93. Benitec Biopharma Limited (Australia) Product
Table 94. Benitec Biopharma Limited (Australia) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 95. Benitec Biopharma Limited (Australia) Recent Development
Table 96. Genzyme Corporation (USA) Company Details
Table 97. Genzyme Corporation (USA) Business Overview
Table 98. Genzyme Corporation (USA) Product
Table 99. Genzyme Corporation (USA) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 100. Genzyme Corporation (USA) Recent Development
Table 101. Silence Therapeutics PLC (UK) Business Overview
Table 102. Silence Therapeutics PLC (UK) Product
Table 103. Silence Therapeutics PLC (UK) Company Details
Table 104. Silence Therapeutics PLC (UK) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 105. Silence Therapeutics PLC (UK) Recent Development
Table 106. Cenix BioScience GmbH (Germany) Company Details
Table 107. Cenix BioScience GmbH (Germany) Business Overview
Table 108. Cenix BioScience GmbH (Germany) Product
Table 109. Cenix BioScience GmbH (Germany) Revenue in RNA Based Therapeutics Business (2015-2020) (Million US$)
Table 110. Cenix BioScience GmbH (Germany) Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global RNA Based Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. qRT-PCR Features
Figure 3. RNA Interference (RNAi) Technologies Features
Figure 4. RNA Antisense Features
Figure 5. Inhibition Features
Figure 6. Microarrays Features
Figure 7. Labeling Features
Figure 8. Purification Features
Figure 9. Global RNA Based Therapeutics Market Share by Application: 2020 VS 2026
Figure 10. Cardiovascular Case Studies
Figure 11. Kidney Diseases Case Studies
Figure 12. Oncology Case Studies
Figure 13. Infectious Diseases Case Studies
Figure 14. Metabolic Disorders Case Studies
Figure 15. RNA Based Therapeutics Report Years Considered
Figure 16. Global RNA Based Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global RNA Based Therapeutics Market Share by Regions: 2020 VS 2026
Figure 18. Global RNA Based Therapeutics Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global RNA Based Therapeutics Market Share by Players in 2019
Figure 21. Global Top RNA Based Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Based Therapeutics as of 2019
Figure 22. The Top 10 and 5 Players Market Share by RNA Based Therapeutics Revenue in 2019
Figure 23. North America RNA Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe RNA Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China RNA Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan RNA Based Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. ISIS pharmaceuticals (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. ISIS pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 29. Quark Pharmaceuticals (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Quark Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 31. Alnylam Pharmaceuticals (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alnylam Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 33. Dicerna Pharmaceuticals (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Dicerna Pharmaceuticals (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 35. Tekmira Pharmaceuticals Corp. (Canada) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Tekmira Pharmaceuticals Corp. (Canada) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 37. Benitec Biopharma Limited (Australia) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Benitec Biopharma Limited (Australia) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 39. Genzyme Corporation (USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Genzyme Corporation (USA) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 41. Silence Therapeutics PLC (UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Silence Therapeutics PLC (UK) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 43. Cenix BioScience GmbH (Germany) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Cenix BioScience GmbH (Germany) Revenue Growth Rate in RNA Based Therapeutics Business (2015-2020)
Figure 45. Bottom-up and Top-down Approaches for This Report
Figure 46. Data Triangulation
Figure 47. Key Executives Interviewed